The conference is six weeks away! Register now!


The Faillace Department of Psychiatry and Behavioral Sciences, our department chair Jair Soares, MD, PhD, and course director Marsal Sanches, MD, PhD, invite you to join us for the 2024 UTHealth Houston Mood Disorders Conference: Bipolar Disorder Across the Lifespan.


Registration is now open! The conference is open to all health care professionals, including nurses, social workers, physicians, residents, fellows, students and other trainees, and the general public. Up to 11 education credits are available over this two-day conference. Breakfast, lunch, and refreshments will be provided.


For questions contact Aaron Zapata, marketing coordinator.

Register

Temple and team start UTHealth Houston Center for Violence Prevention


Along with his UTHealth Houston colleagues, Jeff Temple, PhD, professor, associate dean for clinical research at UTHealth Houston School of Behavioral Health Sciences, is launching the UTHealth Houston Center for Violence Prevention (CVP), which was founded to reduce the burden of violence in Texas and across the United States through research, best practices, policymaking, evaluation, training, and partnerships with community agencies.


Full story

Jeff Temple, PhD

YAMBassadors Summer Mentorship Program completes first year


The UTHealth Houston Youth Aware of Mental Health Program (YAM) celebrated seven high school students who completed the inaugural YAMBassadors Summer Mentorship Program on Friday, Aug. 2, 2024.


Full Story

2024 Research Day provides valuable opportunity for young investigators


The third UTHealth Houston Psychiatry Research Day, paused during the COVID-19 pandemic, was held Wednesday, Aug. 14, with the enthusiastic support of Scott Lane, PhD; Anilkumar Pillai, PhD; and Vineeth John, MD, MBA.


Full Story

Zhao named honorable mention for NIMH Outstanding Resident Award


Ning Olivia Zhao, MD, third-year resident at McGovern Medical School at UTHealth Houston, has been awarded honorable mention recognition for the 2024 NIMH Outstanding Resident Award.


The NIMH Outstanding Resident Award Program was introduced to the psychiatry residency training community more than 30 years ago to recognize residents with outstanding research and academic potential.

Clinical trials

The following clinical trials are in operation, following all necessary safety guidelines. If you're interested, contact the appropriate study.


The Effects of Abstinence on EEG Power and Attention in Cocaine Use Disorder

The purpose of this study is to compare the brain processes involved in the attention of current cocaine users and those who have been abstinent for at least one month. These brain responses are expected to help us understand how the brain recovers after no longer using cocaine and to identify attention problems that can be addressed in future treatments.

Contact: 713-500-DRUG (3784)


PEA for Bipolar Depression

The purpose of this six-week study is to test a novel antidepressant medication called PEA (palmitoylethanolamide) in addition to a mood stabilizer for patients with bipolar disorder. This medication is considered a nutraceutical, which works by targeting the endocannabinoid system to reduce inflammation and may help reduce symptoms of depression.

Contact: 713-486-MOOD (6663)


COVID-19 Bereavement in Youth

The purpose of this study is to increase understanding of pandemic-related bereavement in children and adolescents.

Contact: psy.ccbstudy@uth.tmc.edu


Exploring Consumer and Patient Internet Searches and Activities Related to the Diagnosis and Engagement in Treatment for Alcohol Use Disorder (AUD)

Contact: Ijeoma Acholonu - ijeoma.acholonu@uth.tmc.edu


To see all open studies, visit our website.

Publications
In the news

Antidepressant Effect of Sodium Butyrate is Accompanied by Brain Epigenetic Modulation in Rats Subjected to Early or Late Life Stress - Pub Med - July 2024

Samira Silva ValvassoriRoger Bitencourt VarelaWilson Rodrigues Resende, Taise Possamai-Della, Laura de Araujo BorbaJoão Paulo BehenckGislaine Zilli RéusJoão Quevedo


A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder - PubMed - April 2024

Gregory H Jones, Courtney M VeceraAna C RuizHanjing E WuSophia I McInturffMaria J OrejarenaKacy A SmithJair C SoaresCarlos A ZarateScott D LaneRodrigo Machado-Vieira


Connecting, Serving, and Adapting: Perspectives on the Transition to Adulthood from Latino Young Adults with ASD, Parents, and Providers - Journal of Developmental and Physical Disabilities - August 2024

Pagán, A.F., Vanderburg, J. L., Loveland, K. A., Acierno, R. & Meyer, T. D. 


Building resilience: A specialty clinic tailored to older adults at risk of violence and abuse - Sage Journals - August 2024

Hernandez-Tejada, M. A., Little, D. M., Bruce, M. J., Butte, S., Burnett, J., Wood, L., & Acierno, R


Cesar Soutullo, MD, PhD, was interviewed by Univision Houston Channel 45 about back-to-school anxiety (11:45).


Lokesh Shahani, MD, PhD, MPH, was interviewed by KHOU-TV Channel 11 about signs of grief in children and how parents can help. 


Jeff Temple, PhD, was interviewed by FOX 26 News about recognizing the signs of domestic violence in light of the newly released movie, “It Ends With Us.”


Luba Yammine, PhD, was quoted in a Yahoo! Life article about a new study that found GLP-1 agonists can help people combat their smoking addiction. 


Yammine also spoke with KHOU-TV Channel 11 about her research on GLP-1 agonists and smoking cessation.


Michael Weaver, MD, was interviewed by the Houston Chronicle about kratom and the drug’s uses. 


Join our mail list
We appreciate your donation!
Contact us

Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston

713-486-2500

Email

Website

Connect with us:
Facebook  Twitter  Instagram